A compact fully automated chemiluminescence immunoassay analyzer with a detection speed of 200 tests per hour and first result within 15 minutes, with precision ≤3%. It features highly integrated and simplified design with high floor efficiency, space-saving dimensions of 0.51m³, touchscreen operati...
Manufactured by
DiYaLab ZJG Biotech Co., Ltd.
Zhangjiagang, Jiangsu, China
DiYaLab ZJG Biotech Co., Ltd established in 2016, focuses on developing laboratory testing products for Autoimmune and Neurological diseases. With two R D centers in Shanghai and Zhangjiagang, the company occupies a total of approximately 4,000 square meters for R D, production, and office spaces, and has obtained ISO 13485 international quality system certification. The company has been granted 50+ national patents (including 9 invention patents) and is recognized as a high-tech enterprise. 86 of its products have been registered and approved by the National Medical Products Administration (NMPA) for market launch, while 84 products have obtained EU CE certification and are sold globally. As a developer and manufacturer of laboratory testing products for autoimmune and neurological diseases, the company s team continues to tackle cutting-edge technologies related to the expression and purification of ion channel-type large transmembrane proteins, addressing challenges posed by foreign monopolies in critical areas. Its independently developed click chemistry phospholipid complex antigen synthesis technology based on β2-glycoprotein I has filled a technological gap and successfully received national invention patent authorization. The highly sensitive single-molecule neurological disease detection system currently under development is set to break through sensitivity limitations imposed by the blood-brain barrier, enabling single-molecule detection of multiple biomarkers in blood samples. This system will be widely applicable for early diagnosis and efficacy monitoring of neurological autoimmune diseases, cerebrovascular diseases, and neurodegenerative disorders.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangdong Fapon Biotech Co., Ltd.
China · 1 relevant product
Quaero Life Science Co.,Ltd.
China · 4 relevant products
Beijing Strong Biotechnologies, Inc.
China · 5 relevant products
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 29 relevant matches
Quaero Life Science Co.,Ltd. · China
An automated immunoassay analyzer using direct/enzymatic chemiluminescence analysis technology. Capable of 360 tests per hour with single-use consumables, random sampling, and a 2-hour off-machine time.
Quaero Life Science Co.,Ltd. · China
An automated immunoassay analyzer using direct/enzymatic chemiluminescence analysis technology. Capable of 500 tests per hour with configurable automatic loading for over 25 reagent positions.
Quaero Life Science Co.,Ltd. · China
An automated immunoassay analyzer using photoactivated chemiluminescence technology. Capable of 600 tests per hour with support for random sampling or batch processing.
26 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products